This clinical trial tests the accuracy of a self-collected Papanicolaou test (Pap smear) versus in-clinic screening by a healthcare professional in a clinical setting. Currently, cervical cancer screening in the United States is typically performed by a healthcare provider in the clinical setting. However, self-sampling has been shown to be a viable screening strategy among underserved populations. Information gained from this study may help researchers determine whether self-collected Pap smears are as accurate as provider-collected Pap smears.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04093388.
Locations matching your search criteria
United States
Alabama
Birmingham
University of Alabama at Birmingham Cancer CenterStatus: Active
Contact: John B. Waits
Phone: 205-312-8080
PRIMARY OBJECTIVES:
I. To test the accuracy of patient self-administered Papanicolaou test (Pap smear) versus in-clinic screening by a healthcare professional in the clinical setting.
II. To study the experience of taking a self-administered Pap smear with the use of a short questionnaire.
OUTLINE:
Participants watch an educational video on Pap smears and then undergo a self-collected vaginal swab sample over 10 minutes and then a healthcare provider-collected vaginal swab sample over 5 minutes on study.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationUniversity of Alabama at Birmingham Cancer Center
Principal InvestigatorJohn B. Waits
